Clinical trial

Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in…

NCT00306111 · University Hospital Tuebingen, Other · Completed

Key facts

NCT number NCT00306111
Title Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma
Official title Pegfilgrastim Versus Filgrastim - Intraindividual Comparison of Quantity and Quality of Mobilized Peripheral Blood Stem Cells in Patients With Non Hodgkin-lymphoma
Lead sponsor University Hospital Tuebingen, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions Non-Hodgkin Lymphoma
Intervention type Drug
Interventions pegfilgrastim
Enrollment 14
Start date Jan 1, 2006
Primary completion Dec 1, 2008
Completion Dec 1, 2011
First posted Mar 22, 2006
Last update posted May 29, 2014
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies